SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001454982-09-000140
Filing Date
2009-10-06
Accepted
2009-10-06 18:42:33
Documents
1
Period of Report
2009-10-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3829
  Complete submission text file 0001454982-09-000140.txt   5498
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
ALTMAN STEVEN R (Reporting) CIK: 0001191307 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19700 | Film No.: 091108997